PID1
Basic information
Region (hg38): 2:228850526-229271287
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (31 variants)
- PID1-related_disorder (2 variants)
- Moyamoya_angiopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PID1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001100818.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 31 | 34 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 1 | 31 | 2 | 0 |
Highest pathogenic variant AF is 0.000016108506
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PID1 | protein_coding | protein_coding | ENST00000392054 | 3 | 420760 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00315 | 0.834 | 125686 | 0 | 3 | 125689 | 0.0000119 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.269 | 138 | 147 | 0.938 | 0.00000871 | 1658 |
| Missense in Polyphen | 48 | 61.232 | 0.7839 | 642 | ||
| Synonymous | -0.0667 | 66 | 65.3 | 1.01 | 0.00000469 | 469 |
| Loss of Function | 1.16 | 5 | 8.68 | 0.576 | 4.55e-7 | 99 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.000101 | 0.0000993 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Increases proliferation of preadipocytes without affecting adipocytic differentiation. {ECO:0000269|PubMed:16815647}.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.0462
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.37
Haploinsufficiency Scores
- pHI
- 0.213
- hipred
- N
- hipred_score
- 0.332
- ghis
- 0.597
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0883
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pid1
- Phenotype
Gene ontology
- Biological process
- negative regulation of protein phosphorylation;energy reserve metabolic process;positive regulation of gene expression;regulation of mitochondrial fusion;cellular response to leptin stimulus;fat cell differentiation;positive regulation of transcription by RNA polymerase II;negative regulation of glucose import;negative regulation of insulin receptor signaling pathway;regulation of mitochondrial membrane potential;positive regulation of fat cell proliferation;mitochondrion morphogenesis;cellular response to cytokine stimulus;cellular response to interleukin-6;cellular response to tumor necrosis factor;cellular response to fatty acid;negative regulation of protein localization to plasma membrane;regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of ATP biosynthetic process;positive regulation of ATP biosynthetic process
- Cellular component
- cytoplasm
- Molecular function
- protein binding